Page last updated: 2024-08-23

paroxetine and 1-naphthylamine

paroxetine has been researched along with 1-naphthylamine in 88 studies

Research

Studies (88)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's88 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR1
Grimsley, SR; Jann, MW1
DeVane, CL1
Johnson, AM; Tulloch, IF1
Goodman, WK; McDougle, CJ; Price, LH1
Koe, BK; Lebel, LA; Welch, WM1
Rickels, K; Schweizer, E1
Rothschild, AJ1
Baumann, P; Rochat, B1
Preskorn, SH3
Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S1
Finley, PR1
Hyttel, J; Sánchez, C1
Frost, L; Lal, S1
Jaffe, IA1
Althof, SE1
Helmeste, DM; Reist, C; Tang, SW; Vu, R1
Barrett, J1
Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF1
Preskorn, S1
Domino, EF; Holmes, RD; Lee, A; Markel, H1
Deltito, JA1
Cline, EJ; Kim, S; Kuhar, MJ; Scheffel, U1
Iacono, RP; Toyama, SC1
Bergeron, R; De Montigny, C; Debonnel, G1
Kupfer, DJ1
LaBranche, S1
Hsu, JH; Shen, WW1
Burke, MJ; Harvey, AT; Preskorn, SH1
Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT1
Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA1
Newhouse, PA1
Gammon, GD1
Lazowick, AL; Levin, GM1
García-Rodríguez, JA; Muñoz-Bellido, JL; Muñoz-Criado, S1
Balon, R1
Knowles, SR; Liu, BA; Mittmann, N; Shear, NH1
Fava, GA; Grandi, S1
Lesaca, TG1
Reynolds, CF1
Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH1
Harvey, AT; Preskorn, SH1
Bell, CJ; Coupland, NJ; Potokar, JP1
Bryant, SG1
Cowen, PJ; McTavish, SF; Williamson, DJ1
Leo, RJ1
Harnett-Sheehan, K; Sheehan, DV1
de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR1
Kurz, X; Ottervanger, JP; Roisin, T; Stricker, BH; Van Ermen, AM1
Franchini, L; Gasperini, M; Perez, J; Smeraldi, E; Zanardi, R1
Baumann, P; Eap, CB1
MacKay, AV; Price, JS; Waller, PC; Wood, SM1
Rifkin, A1
Meier, E; Sánchez, C1
Charness, WE; Ferrando, SJ; Goldman, JD1
Earley, B; Faherty, CJ; Leonard, BE1
Devine, CL; Markowitz, JS1
DePalma, RL; Katholi, CR; Modell, JD; Modell, JG1
Darby, AL; Lesser, IM; Miller, BL; Swartz, JR1
Constantino, JN; Kincaid, M; Liberman, M1
Burke, WJ; Dewan, V; Folks, DG; Nadolny, GC; Roccaforte, WH; Wengel, SP1
Ahern, D; Ball, SE; Kao, J; Scatina, J1
Di Mascio, M; Esposito, E1
Alderman, J; Allison, J; Chung, M; Greenblatt, DJ; Harrison, W; Penenberg, D; Preskorn, SH1
Mitchell, S; Tracy, KA; Zajecka, J1
Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E1
Richelson, E1
Bagby, RM; Dickens, SE; Joffe, R; Kennedy, SH; Levitt, A; Minifie, CE; Schuller, DR1
Gregor, KJ; James, SP; Way, K; Young, CH1
Gorman, JM1
Cohen, CI; Trappler, B1
Edwards, IR; Fletcher, AP; Lindquist, M; Pettersson, M; Sanderson, JH; Schou, JS; Stahl, MM; Taylor, NF1
Buesching, DP; Croghan, TW; Crown, WH; Heiligenstein, JH; Hylan, TR; Melfi, CA; Meneades, L1
Brochu, J; Cook, L; Feldkamp, M; Koren, G; Kulin, NA; Matsui, D; Ormond, K; Pastuszak, A; Rieder, M; Sage, SR; Schick-Boschetto, B; Spivey, G; Stein-Schechman, AK1
Fawcett, J; Mitchell, S; Zajecka, J1
Grimes, JB; Hines, A; Labbate, LA; Pollack, MH1
Andrews, W; Barrett, E; Parker, G1
Arana, GW; Grimes, JB; Labbate, LA1
Grush, LR1
Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF1
Beach, K; Dougherty, D; Hilal, R; Nesbitt, L; Sallee, FR1
Amey, M; Baumann, P; Bouchoux, G; Cochard, N; Eap, CB; Savary, L1
Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P1
Roose, SP; Suthers, KM1
Navarro, R; Spangler, M; Valler, WE1

Reviews

26 review(s) available for paroxetine and 1-naphthylamine

ArticleYear
Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
    Clinical pharmacy, 1992, Volume: 11, Issue:11

    Topics: 1-Naphthylamine; Depressive Disorder; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1992
Pharmacokinetics of the selective serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline

1992
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline

1992
Pharmacotherapy of obsessive compulsive disorder.
    The Journal of clinical psychiatry, 1992, Volume: 53 Suppl

    Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline

1992
Clinical overview of serotonin reuptake inhibitors.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl B

    Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine

1990
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
    International clinical psychopharmacology, 1995, Volume: 10 Suppl 1

    Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism

1995
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
    The Journal of clinical psychiatry, 1995, Volume: 56 Suppl 6

    Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride

1995
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:12

    Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Pharmacologic treatment of rapid ejaculation.
    The Psychiatric clinics of North America, 1995, Volume: 18, Issue:1

    Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride

1995
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
    International clinical psychopharmacology, 1994, Volume: 9 Suppl 3

    Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Half-Life; Humans; Metabolic Clearance Rate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Management of recurrent depression.
    The Journal of clinical psychiatry, 1993, Volume: 54 Suppl

    Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline

1993
[New antidepressive agents].
    L'union medicale du Canada, 1995, Volume: 124, Issue:3

    Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Use of serotonin selective reuptake inhibitors in geriatric depression.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 5

    Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Antidepressants in the treatment of premature ejaculation.
    Journal of sex & marital therapy, 1996,Summer, Volume: 22, Issue:2

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological

1996
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1996, Sep-01, Volume: 155, Issue:5

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Female; Fluoxetine; Fluvoxamine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Depression: making the diagnosis and using SSRIs in the older patient.
    Geriatrics, 1996, Volume: 51, Issue:10

    Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
    Drug safety, 1996, Volume: 15, Issue:2

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan

1996
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5

    Topics: 1-Naphthylamine; Animals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Movement disorders associated with the serotonin selective reuptake inhibitors.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:10

    Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States

1996
The role of SSRIs in panic disorder.
    The Journal of clinical psychiatry, 1996, Volume: 57 Suppl 10

    Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
    Journal of chromatography. B, Biomedical applications, 1996, Nov-08, Volume: 686, Issue:1

    Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7

    Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

1997
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Journal of sex & marital therapy, 1997,Fall, Volume: 23, Issue:3

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires

1997
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
    Mayo Clinic proceedings, 1997, Volume: 72, Issue:9

    Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

1997
The use of newer antidepressants for panic disorder.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 14

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

1997
Antidepressant response in late-life depression.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 10

    Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1998

Trials

13 trial(s) available for paroxetine and 1-naphthylamine

ArticleYear
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
    The American journal of psychiatry, 1995, Volume: 152, Issue:10

    Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological

1995
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
    Journal of affective disorders, 1994, Volume: 31, Issue:3

    Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
Response to an open trial of a second SSRI in major depression.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:3

    Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
    The American journal of psychiatry, 1996, Volume: 153, Issue:12

    Topics: 1-Naphthylamine; Delusions; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hospitalization; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1996
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
    General hospital psychiatry, 1997, Volume: 19, Issue:2

    Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders

1997
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:5

    Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome

1997
Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial.
    Journal of child and adolescent psychopharmacology, 1997,Spring, Volume: 7, Issue:1

    Topics: 1-Naphthylamine; Adolescent; Aggression; Female; Fluoxetine; Humans; Inpatients; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:4

    Topics: 1-Naphthylamine; Adolescent; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Area Under Curve; Cross-Over Studies; Desipramine; Drug Interactions; Drug Therapy, Combination; Electrocardiography; Humans; Male; Middle Aged; Paroxetine; Sertraline

1997
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
    Journal of sex & marital therapy, 1997,Fall, Volume: 23, Issue:3

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires

1997
Differential pharmacological treatment response in high angry hostile and low angry hostile depressed patients: a retrospective analysis.
    Journal of affective disorders, 1997, Volume: 45, Issue:3

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Analysis of Variance; Anger; Cyclohexanols; Depressive Disorder; Desipramine; Female; Hostility; Humans; Male; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

1997
Use of SSRIs in "very old" depressed nursing home residents.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 1998,Winter, Volume: 6, Issue:1

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric

1998
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders.
    Biological psychiatry, 1998, Jun-15, Volume: 43, Issue:12

    Topics: 1-Naphthylamine; Adult; Anxiety; Ejaculation; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Paroxetine; Penile Erection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological

1998
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Biological psychiatry, 1998, Jul-15, Volume: 44, Issue:2

    Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires

1998

Other Studies

50 other study(ies) available for paroxetine and 1-naphthylamine

ArticleYear
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
    British journal of clinical pharmacology, 1992, Volume: 34, Issue:3

    Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine

1992
Sertraline (Lustral) and paroxetine (Seroxat)--new drugs for the treatment of depression.
    Drug and therapeutics bulletin, 1991, Jun-10, Volume: 29, Issue:12

    Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Humans; Paroxetine; Piperidines; Sertraline

1991
[3H] sertraline binding to rat brain membranes.
    Psychopharmacology, 1990, Volume: 100, Issue:4

    Topics: 1-Naphthylamine; Animals; Brain; Fenclonine; Fluoxetine; Imipramine; In Vitro Techniques; Male; Membranes; Naphthalenes; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin Antagonists; Sertraline

1990
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
    British journal of pharmacology, 1993, Volume: 110, Issue:1

    Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline

1993
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
    European journal of pharmacology, 1994, Nov-03, Volume: 264, Issue:3

    Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes

1994
Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
    The American journal of psychiatry, 1995, Volume: 152, Issue:5

    Topics: 1-Naphthylamine; Adult; Anxiety Disorders; Electric Injuries; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Substance Withdrawal Syndrome

1995
Serotonin reuptake inhibitors in Raynaud's phenomenon.
    Lancet (London, England), 1995, May-27, Volume: 345, Issue:8961

    Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride

1995
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.
    European journal of pharmacology, 1995, Feb-15, Volume: 288, Issue:3

    Topics: 1-Naphthylamine; Blood Platelets; Calcium; Calmodulin; Cells, Cultured; Fluoxetine; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1995
Anisocoria associated with selective serotonin reuptake inhibitors.
    BMJ (Clinical research ed.), 1994, Dec-17, Volume: 309, Issue:6969

    Topics: 1-Naphthylamine; Adult; Anisocoria; Antidepressive Agents; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1994
LSD flashback syndrome exacerbated by selective serotonin reuptake inhibitor antidepressants in adolescents.
    The Journal of pediatrics, 1994, Volume: 125, Issue:5 Pt 1

    Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depressive Disorder; Drug Interactions; Female; Humans; Lysergic Acid Diethylamide; Male; Paroxetine; Recurrence; Sertraline; Substance-Related Disorders; Syndrome

1994
Valproate pretreatment for the difficult-to-treat patient with OCD.
    The Journal of clinical psychiatry, 1994, Volume: 55, Issue:11

    Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid

1994
Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.
    Synapse (New York, N.Y.), 1994, Volume: 16, Issue:4

    Topics: 1-Naphthylamine; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Cocaine; Fluoxetine; Hypothalamus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline

1994
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
    The Annals of pharmacotherapy, 1994, Volume: 28, Issue:3

    Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline

1994
Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands.
    European journal of pharmacology, 1993, Aug-24, Volume: 240, Issue:2-3

    Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Clorgyline; Electrophysiology; Haloperidol; Male; N-Methylaspartate; Paroxetine; Pyramidal Cells; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sertraline; Tranylcypromine

1993
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
    International journal of psychiatry in medicine, 1995, Volume: 25, Issue:3

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological

1995
Pharmacokinetics of the newer antidepressants.
    The American journal of medicine, 1996, Volume: 100, Issue:1

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Desipramine; Fluoxetine; Humans; Isoenzymes; Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Drug-drug interactions.
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:5

    Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
    The American journal of psychiatry, 1996, Volume: 153, Issue:6

    Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical

1996
Incentive bias?
    The Journal of clinical psychiatry, 1996, Volume: 57, Issue:6

    Topics: 1-Naphthylamine; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Costs; Drug Industry; Financial Support; Humans; Paroxetine; Prejudice; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Potential withdrawal syndrome associated with SSRI discontinuation.
    The Annals of pharmacotherapy, 1995, Volume: 29, Issue:12

    Topics: 1-Naphthylamine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1995
In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
    The Journal of antimicrobial chemotherapy, 1996, Volume: 37, Issue:5

    Topics: 1-Naphthylamine; Amoxicillin; Anti-Bacterial Agents; Antidepressive Agents; Cefotaxime; Corynebacterium; Drug Therapy, Combination; Gentamicins; Microbial Sensitivity Tests; Paroxetine; Risperidone; Serotonin Antagonists; Sertraline; Teicoplanin; Vancomycin

1996
Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:5

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1995
Sertraline and galactorrhea.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:4

    Topics: 1-Naphthylamine; Adult; Depressive Disorder; Female; Galactorrhea; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Serotonin reuptake inhibitor withdrawal.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:5

    Topics: 1-Naphthylamine; Adolescent; Adult; Age Factors; Clomipramine; Dizziness; Female; Fluvoxamine; Humans; Male; Middle Aged; Paresthesia; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Substance Withdrawal Syndrome

1996
Reassessment of nefazodone.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996, Oct-01, Volume: 53, Issue:19

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Humans; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles

1996
Effect of valine on 5-HT neurotransmission and mood.
    Advances in experimental medicine and biology, 1996, Volume: 398

    Topics: 1-Naphthylamine; Adult; Affect; Amino Acids, Branched-Chain; Amitriptyline; Analysis of Variance; Antidepressive Agents; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fenfluramine; Humans; Lithium; Male; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Valine

1996
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
    International clinical psychopharmacology, 1996, Volume: 11, Issue:3

    Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method

1996
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].
    Nederlands tijdschrift voor geneeskunde, 1996, Sep-07, Volume: 140, Issue:36

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Belgium; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline

1996
Effects of antidepressants on the cytochrome P450 system.
    The American journal of psychiatry, 1996, Volume: 153, Issue:12

    Topics: 1-Naphthylamine; Antidepressive Agents; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Medical Records; Paroxetine; Research Design; Sertraline

1996
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    British journal of clinical pharmacology, 1996, Volume: 42, Issue:6

    Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1996
SSRI optimal dose remains at issue.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:2

    Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1997
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
    Psychopharmacology, 1997, Volume: 129, Issue:3

    Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal

1997
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
    Journal of psychopharmacology (Oxford, England), 1997, Volume: 11, Issue:1

    Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
    Therapeutic drug monitoring, 1997, Volume: 19, Issue:2

    Topics: 1-Naphthylamine; Antidepressive Agents; Drug Interactions; Fluoxetine; Humans; Paroxetine; Sertraline

1997
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
    Clinical pharmacology and therapeutics, 1997, Volume: 61, Issue:4

    Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Female; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires

1997
The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia.
    International journal of geriatric psychiatry, 1997, Volume: 12, Issue:5

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Dementia; Depressive Disorder; Female; Humans; Male; Paroxetine; Psychotic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
    British journal of clinical pharmacology, 1997, Volume: 43, Issue:6

    Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride

1997
The degree of inhibition of dopaminergic neurons in the ventral tegmental area induced by selective serotonin reuptake inhibitors is a function of the density-power-spectrum of the interspike interval.
    Neuroscience, 1997, Volume: 79, Issue:4

    Topics: 1-Naphthylamine; Animals; Dopamine; Dose-Response Relationship, Drug; Fluvoxamine; Male; Membrane Potentials; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Tegmentum Mesencephali

1997
Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?
    Journal of affective disorders, 1997, Volume: 46, Issue:1

    Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Paroxetine; Psychotropic Drugs; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline

1997
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
    European journal of clinical pharmacology, 1997, Volume: 53, Issue:3-4

    Topics: 1-Naphthylamine; Adverse Drug Reaction Reporting Systems; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; World Health Organization

1997
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
    Journal of affective disorders, 1998, Volume: 47, Issue:1-3

    Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Direct Service Costs; Drug Costs; Fee-for-Service Plans; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Models, Econometric; Multivariate Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States

1998
Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
    JAMA, 1998, Feb-25, Volume: 279, Issue:8

    Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Adult; Antidepressive Agents; Cohort Studies; Female; Fluvoxamine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
    Psychopharmacology bulletin, 1997, Volume: 33, Issue:4

    Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior

1997
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1997, Volume: 9, Issue:4

    Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome

1997
The SSRI antidepressants: exploring their "other" possible properties.
    Journal of affective disorders, 1998, Volume: 49, Issue:2

    Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires

1998
Risk of fetal anomalies with exposure to selective serotonin reuptake inhibitors.
    JAMA, 1998, Jun-17, Volume: 279, Issue:23

    Topics: 1-Naphthylamine; Antidepressive Agents; Female; Fluvoxamine; Humans; Paroxetine; Pregnancy; Pregnancy Outcome; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:7

    Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Blood Platelets; Carrier Proteins; Child; Depressive Disorder; Female; Humans; Kinetics; Male; Paroxetine; Serotonin; Sertraline

1998
Simultaneous determination of human plasma levels of citalopram, paroxetine, sertraline, and their metabolites by gas chromatography-mass spectrometry.
    Journal of chromatographic science, 1998, Volume: 36, Issue:7

    Topics: 1-Naphthylamine; Citalopram; Drug Monitoring; Gas Chromatography-Mass Spectrometry; Humans; Paroxetine; Quality Control; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
    European journal of clinical pharmacology, 1998, Volume: 54, Issue:3

    Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline

1998
Antidepressant utilization in managed care: an evaluation of SSRI use in two HMO settings.
    Medical interface, 1995, Volume: 8, Issue:8

    Topics: 1-Naphthylamine; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Drug Costs; Drug Utilization Review; Fluoxetine; Humans; Managed Care Programs; Models, Organizational; Paroxetine; Selective Serotonin Reuptake Inhibitors; Time Factors; United States

1995